• Harvard Bioscience held its annual shareholder meeting on June 2, 2026.
• Shareholders backed an amended and restated 2021 incentive plan, raising the share pool by 400,000 shares for future awards.
• Shareholders adopted an amendment to the employee stock purchase plan.
• Shareholders ratified Grant Thornton as independent auditor for the fiscal year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-003877), on June 02, 2026, and is solely responsible for the information contained therein.